Implenia closed the acquisition of BAM Swiss AG
EQS Group-Ad-hoc: Implenia AG / Key word(s): Acquisition/Mergers & Acquisitions With the closing of the acquisition of BAM Swiss AG Implenia becomes a leading construction services provider in the healthcare sector. Dietlikon, 12 May 2021 - With yesterday's closing of the acquisition of BAM Swiss AG Implenia will ensure the timely planning and realisation of the Cantonal Hospital Aarau from a single source. In addition Implenia also takes over BAM Swiss AG's current projects BSSE in Basel - a modern laboratory and research building for biosystems science and engineering - as well as the project Felix Platter-Hospital in Basel and a student residence of the ETH in Zurich.
Contact for media: Contact for Investors and Analysts: Investors' diary: As Switzerland's leading construction and real estate service provider, Implenia develops and builds homes, workplaces and infrastructure for future generations in Switzerland and Germany. It also plans and builds complex infrastructure projects in Austria, France, Sweden and Norway. Formed in 2006, the company can look back on around 150 years of construction tradition. The company brings together the know-how of its highly skilled consulting, planning and execution units under the umbrella of an integrated leading multinational construction and real estate service provider. With its broad offering and the extensive experience of its specialists, the Group can realise complex major projects and provide customer-centric support across the entire life-cycle of a building or structure. It focuses on customer needs and on striking a sustainable balance between commercial success and social and environmental responsibility. Implenia, with its headquarters in Opfikon near Zurich, employs more than 8,500 people in Europe and posted revenue of almost CHF 4 billion in 2020. The company is listed on the SIX Swiss Exchange (IMPN, CH0023868554). More information can be found at implenia.com. End of ad hoc announcement |
Language: | English |
Company: | Implenia AG |
Industriestrasse 24 | |
8305 Dietlikon | |
Switzerland | |
Phone: | +41 58 474 74 74 |
E-mail: | info@implenia.com |
Internet: | www.implenia.com |
ISIN: | CH0023868554 |
Valor: | A0JEGJ |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1195534 |
End of Announcement | EQS Group News Service |
|
1195534 12-May-2021 CET/CEST